• Dr. Reddy's Laboratories Ltd., of Hyderabad, India, declared its public offer to acquire the issued and outstanding shares of OctoPlus NV, of Leiden, the Netherlands, unconditional, with 37.2 million shares tendered during the offering period, representing 70.7 percent of shares.